group
decid
mak
approach
bas
lingu
q-rung
orthopair
fuzzy
yag
pow
weight
geomet
aggreg
op
select
nanopartic
drug
delivery
system
.
lung
cant
remain
on
prev
dead
form
cant
worldwid
high
mort
rat
limit
tre
opt
avail
.
tradit
chemotherapy
rady
therapy
mainstay
lung
cant
tre
eff
oft
limit
system
tox
drug
resist
.
rec
many
nanopartic
ident
cre
drug
delivery
abl
spec
target
tum
cel
spar
healthy
cel
org
.
nanoparticle-based
drug
delivery
system
off
distinct
benefit
conv
med
delivery
includ
increas
perm
ret
effect
precid
target
improv
stabl
biocompat
.
theref
pap
propos
group
decid
mak
approach
lingu
q-rung
orthopair
fuzzy
environ
select
best
nanopartic
drug
delivery
system
lung
cant
tre
.
first
pap
propos
lingu
q-rung
orthopair
fuzzy
yag
pow
weight
geomet
aggreg
op
aggreg
lingu
q-rung
orthopair
fuzzy
numb
bas
yag
norm
.
pap
also
demonst
sev
feat
propos
op
.
moreov
us
propos
op
pap
pres
group
decid
mak
approach
.
furtherm
cas
study
pres
select
optim
nanopartic
drug
delivery
tre
lung
cant
demonst
propos
decid
mak
approach
appl
.
fin
pap
pres
comparison
study
sensit
analys
supery
propos
decid
mak
approach
ex
decid
mak
method
valid
propos
decid
mak
approach
.